Two Sigma Securities, LLC Dare Bioscience, Inc. Transaction History

Two Sigma Securities, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $0.61 $19,489 - $42,458	69,604 Added 209.07%	102,896 $34,000
Q1 2024 May 15, 2024	BUY	$0.31 - $0.57 $10,320 - $18,976	33,292 New	33,292 $16,000
Q3 2023 Nov 14, 2023	BUY	$0.46 - $0.91 $10,799 - $21,364	23,477 New	23,477 $10,000
Q1 2022 May 16, 2022	SELL	$1.42 - $2.09 $16,496 - $24,279	-11,617 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.42 - $2.13 $16,496 - $24,744	11,617 New	11,617 $23,000
Q3 2021 Nov 15, 2021	SELL	$1.42 - $2.0 $63,039 - $88,788	-44,394 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.21 - $1.89 $53,716 - $83,904	44,394 New	44,394 $84,000
Q2 2019 Aug 14, 2019	SELL	$0.79 - $1.66 $16,617 - $34,918	-21,035 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$0.73 - $2.1 $15,355 - $44,173	21,035 New	21,035 $29,000
Q2 2018 Aug 14, 2018	SELL	$0.76 - $1.48 $10,329 - $20,114	-13,591 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$0.83 - $2.79 $11,280 - $37,918	13,591 New	13,591 $11,000

267K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $270M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.